Drug-Eluting Balloon Market Size, Segments, and Trends by 2031
Drug-Eluting Balloon Market: Size and Share
-
CAGR (2023 - 2031)17.5% -
Market Size 2021
US$ 762.56 Million -
Market Size 2031
US$ 3663.64 Million
Market Dynamics
- Significantly Rising Vascular Disease Incidences
- Rising Use of Drug-eluting Balloons Over Drug Eluting Stents
- Growing Product Innovations, Approvals and Launches to Favor Market
Market Segmentation
Product Type - Peripheral Drug Eluting Balloons
- Coronary Drug Eluting Balloons
- Other Product Types
End User - Hospitals
- Ambulatory Surgical Centers
- Cath Labs & Cardiac Centers
Drug-Eluting Balloon Market Players Density: Understanding Its Impact on Business Dynamics
The Drug-Eluting Balloon Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Drug-Eluting Balloon Market are:
- Medtronic plc
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cook Medical
- B. Braun Melsungen AG
- Koninklijke Philips N.V.
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Drug-Eluting Balloon Market top key players overview
Get Free Sample For